Search

Dr. Craig Thompson, Dr. Peter Bach, Dr. Ushma Neill, and Dr. William Rosa were recognized for their professional, civic, and philanthropic achievements.

… Monday, July 12, 2021 Memorial Sloan Kettering is proud to announce that President & Chief Executive Officer Craig B. Thompson, MD , Director of the Center for Health Policy and Outcomes Peter B. Bach, MD, Vice President of Scientific Education & Training Ushma Neill, PhD , and Postdoctoral Research

The May 13 installment of “MSK Science Spotlight” will feature co-winner of The Society of Memorial Sloan Kettering Prize, Carl June, MD.

… Wednesday, May 13, 2020 The May 13 installment of “MSK Science Spotlight” will feature co-winner of The Society of Memorial Sloan Kettering Prize, Carl June, MD. Dr. June is Director of the Center for Cellular Immunotherapies and Professor, Department of Pathology and Laboratory Medicine, Perelman School

Learn how proton therapy can be an effective new treatment for leptomeningeal metastasis.

… Monday, June 6, 2022 Leptomeningeal metastasis (LM) is a serious condition in which cancer spreads to the fluid and tissues surrounding the brain and spinal cord. This complication can have devastating effects, causing pain, seizures, difficulty thinking, and a loss of muscle control. Treatment with

In honor of Women's History Month, meet the scientific hero who shook up cancer research with her unusual findings.

… Wednesday, March 13, 2019 Summary In honor of Women’s History Month, we’re remembering female scientists from MSK’s past who shook up cancer research. Read about Ora Rosen and  Mathilde Krim . In the 1950s, the idea that cancer might be caused by a virus was somewhat heretical. Most known viruses caused

In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life.

… Saturday, July 1, 2023 Dear MSK Community, In cancer care, firsts make a difference: The first tests that diagnosis the disease. The first choices about where to be treated. The first decisions about how to treat it. At Memorial Sloan Kettering Cancer Center (MSK), we are constantly improving how we

More than 30,000 oncology professionals from around the world will gather in Chicago from May 31 to June 4 for the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. For more information and to set up interviews, email [email protected]. Follow the meeting live on Twitter using the hashtag #ASCO19 and follow MSK on Twitter at @sloan_kettering.

… Wednesday, May 29, 2019 More than 30,000 oncology professionals from around the world will gather in Chicago from May 31 to June 4 for the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. MSK scientists and physicians will take part in nearly 140 presentations from plenary sessions to

We asked. You answered. Get advice from members of the MSK community on dealing with and alleviating anxiety.

… Monday, August 26, 2019 Summary After reaching the end of active cancer treatment, some people may assume that going for follow-up tests would be easy. However, the anxiety around having scans can be overwhelming. Anxiety leading up to doctors’ visits and having scans (sometimes referred to as “scanxiety

A new technology shows great promise for imaging and treating advanced forms of prostate cancer.

… Thursday, July 1, 2021 A transformation is coming for patients with prostate cancer , says Memorial Sloan Kettering medical oncologist Michael Morris . Researchers at MSK have helped pioneer major advances that will enable doctors to pinpoint the location of prostate cancer cells more precisely than

Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

… Tuesday, May 14, 2013 Summary Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer. This image shows melanocytes – cells that protect the skin from ultraviolet radiation – created in a Memorial Sloan Kettering laboratory using

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.

… Thursday, July 10, 2025 Deaths from cancer have fallen dramatically. They’ve dropped by 34% over the past three decades — largely thanks to better treatments, earlier detection, and fewer people smoking. But cancer metastasis remains a stubborn threat. Metastasis is the name for cancer that has spread